A serial biotech startup team is back in business, armed with $40M and a focus on NASH
Bob Baltera’s last stint as a biotech CEO was brief. In less than a year at the helm of Laguna he and the company produced …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
